Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...

In the latest close session, Viking Therapeutics, Inc. (VKTX) was up +1.7% at $28.19. The stock outperformed the S&P 500, which registered a daily gain of 0.83%. Elsewhere, the Dow saw an upswing of 0 ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific ...

Viking Therapeutics begins Phase 3 trials for VK2735, testing weekly injections in over 5,000 adults with obesity or type 2 diabetes over 78 weeks.

Investors in Viking Therapeutics Inc (Symbol: VKTX) saw new options begin trading today, for the August 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

A high-level overview of Viking Therapeutics, Inc. (VKTX) stock. View (VKTX) real-time stock price, chart, news, analysis, analyst reviews and more.

Understand the cash flow statement for Viking Therapeutics, Inc. (VKTX), learn where the money comes from and how the company spends it.

Review Viking Therapeutics Inc (VKTX:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.